Product Information
HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.0373 per EA under NDC 23155076401. Its NADAC has been published 154 times since Sep 13, 2023.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155076401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085182FDA Approved
Before 1982
TE Code
AB
On Market Since
5/2/2023
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 154 times since Sep 13, 2023, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0373 per EA |
|---|---|
| All-time high | $0.0514 (Feb 14, 2024) |
| All-time low | $0.0345 (Nov 20, 2024) |
| 52-week high | $0.0429 |
| 52-week low | $0.0373 |
| Median price | $0.0436 |
| Average price | $0.0445 |
| Largest weekly change | -28.3% (Nov 20, 2024) |
| Weeks tracked | 154 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Heritage Pharmaceuticals Inc., is $0.0373 per EA (NDC 23155076401), effective Aug 19, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has declined 21.2%. It has been tracked across 154 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?
Since Sep 13, 2023, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0345 (Nov 20, 2024) to a high of $0.0514 (Feb 14, 2024), with a median of $0.0436 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROCHLOROTHIAZIDE 12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?
HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 23155076401) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.